Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,101
  • Shares Outstanding, K 37,644
  • Annual Sales, $ 52,350 K
  • Annual Income, $ -18,710 K
  • EBIT $ -22 M
  • EBITDA $ -21 M
  • 60-Month Beta 1.27
  • Price/Sales 1.12
  • Price/Cash Flow N/A
  • Price/Book 4.83

Options Overview Details

View History
  • Implied Volatility 167.73% ( -0.48%)
  • Historical Volatility 119.62%
  • IV Percentile 83%
  • IV Rank 24.66%
  • IV High 367.02% on 03/22/24
  • IV Low 102.49% on 10/04/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 229
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 7,811
  • Open Int (30-Day) 7,766

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +31.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3300 +18.05%
on 11/21/24
1.9500 -19.49%
on 12/11/24
+0.1700 (+12.14%)
since 11/20/24
3-Month
1.1000 +42.73%
on 10/24/24
1.9500 -19.49%
on 12/11/24
+0.2700 (+20.77%)
since 09/20/24
52-Week
0.9670 +62.36%
on 08/05/24
2.8000 -43.93%
on 02/06/24
-0.9300 (-37.20%)
since 12/20/23

Most Recent Stories

More News
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

APYX : 1.5700 (+0.64%)
Apyx: Q3 Earnings Snapshot

Apyx: Q3 Earnings Snapshot

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

APYX : 1.5700 (+0.64%)
Apyx: Q2 Earnings Snapshot

Apyx: Q2 Earnings Snapshot

APYX : 1.5700 (+0.64%)
RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

/PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX), the manufacturer of the proprietary helium plasma and radiofrequency technology marketed and sold as...

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received...

APYX : 1.5700 (+0.64%)
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial...

APYX : 1.5700 (+0.64%)

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

3rd Resistance Point 1.6692
2nd Resistance Point 1.6373
1st Resistance Point 1.6037
Last Price 1.5700
1st Support Level 1.5382
2nd Support Level 1.5063
3rd Support Level 1.4727

See More

52-Week High 2.8000
Fibonacci 61.8% 2.0998
Fibonacci 50% 1.8835
Fibonacci 38.2% 1.6672
Last Price 1.5700
52-Week Low 0.9670

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar